Research
Possible new treatment for Wilson disease seeks to minimize effects on mitochondria using metformin
The Brief
- Wilson disease is a rare genetic condition in which the liver loses the ability to effectively remove copper, so copper accumulates in the body.
- The copper buildup affects the liver, brain, eyes and kidneys and is particularly harmful to mitochondria.
- Researchers have proposed metformin as a possible treatment that seeks to minimize effects on mitochondria.
Why it matters
It offers a possible new treatment direction for a rare copper-retention disorder that aims to limit damage to mitochondria, though the source describes it as a proposal.
Who’s affected
- clinicians and researchers in genetic liver and metabolic disease
- people affected by Wilson disease and their families
- #wilson disease
- #metformin
- #mitochondria
- #copper
- #rare disease
Wilson disease is a rare genetic condition in which the liver loses the ability to effectively remove copper, allowing it to accumulate in the body. This toxic buildup affects the liver, brain, eyes and kidneys and is particularly bad for mitochondria, the cell's all-important…